Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded updated contact phone number (314-498-9799) and collaborator information (Karuna Therapeutics, Inc., a Bristol Myers Squibb company).SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous notices including the funding lapse notice and the earlier Revision: v3.4.1.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no visible changes to the study details; to avoid alerts for small changes, set an alert condition below.SummaryDifference0.0%

- Check31 days agoChange DetectedA site-wide notice about potential delays due to a lapse in government funding has been added, stating information may not be up to date and directing users to cc.nih.gov and opm.gov for updates.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded glossary display and new metadata fields 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and updated the revision to v3.4.0. The previous version showed 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and revision v3.3.4.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision from v3.3.3 to v3.3.4 indicates a minor update with no changes to study content or functionality. To avoid alert fatigue from small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.